Categories: Health&Beauty

European Commission proposes to control two harmful new psychoactive substances

The FINANCIAL –The European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe. The proposal to control the substances is based on risk assessments conducted by the EU drugs agency (EMCDDA) in December 2020.


MDMB-4en-PINACA and 4F-MDMB-BICA are sold as ‘legal’ replacements for cannabis (or already controlled synthetic cannabinoids) and can pose a high risk of severe poisoning. The substances have been detected in smoking mixtures, powders, liquids (including e-liquids) and paper impregnated with the substance (including blotters). Harmful effects linked to the use of the substances were reported by the EU Member States to the EMCDDA through the EU Early Warning System (EWS) according to European Commission.

The two risk assessments were conducted by the EMCDDA Scientific Committee on 7 December 2020, with additional experts from the EU Member States, European Commission, Europol, the European Medicines Agency and the EMCDDA. These examined the health and social risks of the substances, as well as international trafficking and the involvement of organised crime.

At the time of the risk assessments, 12 and 21 deaths with confirmed exposure to MDMB-4en-PINACA and 4F-MDMB-BICA respectively had been reported in the EU.


Today’s proposal from the Commission (the adoption of a delegated directive) is based on the latest legislation designed to bring a stronger and faster response to NPS in Europe . The delegated directive includes the two substances in the definition of ‘drug’ under EU law (4). The European Parliament and the Council will have two months to analyse the act before it enters into force. Once in force, the Member States will have six months to introduce the relevant national legislation.

Of the 35 risk assessments carried out by the EMCDDA, seven have been related to synthetic cannabinoids (5). Products containing synthetic cannabinoids have been available in Europe since around 2006. MDMB-4en-PINACA has been available on the EU drug market since at least 2017 and 4F-MDMB-BICA since March 2020


Since 2005

Recent Posts

Killing In Kherson: A Self-Made Partisan Describes His Role In The Resistance To Russia’s Occupation

KHERSON, Ukraine -- For Vladyslav Nedostup, the eight-month occupation of his native city has receded…

1 hour ago

Casual Luxe & Upscale Fare Featured at Margaritaville Hollywood Beach Resort

Far underrated in comparison to its neighbors Miami and Fort Lauderdale, the city of Hollywood…

1 day ago

Getting ready for retirement

Getting ready for retirement can be both stressful and satisfying. As you get more and…

3 days ago

Macron says it’s up to Ukrainians to decide conditions for possible end of war and “sustainable peace”

French President Emmanuel Macron said he does not believe allies should push Ukrainians into a…

3 days ago

Ukraine war: Kyiv displays dud nuclear-capable missile fired by Russia

Russia is now using nuclear-capable missiles with non-explosive warheads to exhaust Ukraine's air defences, the…

3 days ago

Special Advisor for Caucasus Negotiations, Ambassador Philip Reeker Visits Tbilisi

Philip Reeker, the Senior Advisor of the U.S. State Department for Caucasus Negotiations and the…

3 days ago